Literature DB >> 24031089

Mutations in SLC35A3 cause autism spectrum disorder, epilepsy and arthrogryposis.

Simon Edvardson1, Angel Ashikov, Chaim Jalas, Luisa Sturiale, Avraham Shaag, Anastasia Fedick, Nathan R Treff, Domenico Garozzo, Rita Gerardy-Schahn, Orly Elpeleg.   

Abstract

BACKGROUND: The heritability of autism spectrum disorder is currently estimated at 55%. Identification of the molecular basis of patients with syndromic autism extends our understanding of the pathogenesis of autism in general. The objective of this study was to find the gene mutated in eight patients from a large kindred, who suffered from autism spectrum disorder, arthrogryposis and epilepsy. METHODS AND
RESULTS: By linkage analysis and exome sequencing, we identified deleterious mutations in SLC35A3 in these patients. SLC35A3 encodes the major Golgi uridine diphosphate N-acetylglucosamine (UDP-GlcNAc) transporter. In Golgi vesicles isolated from patient fibroblasts the transport of the respective nucleotide sugar was significantly reduced causing a massive decrease in the content of cell surface expressed highly branched N-glycans and a concomitant sharp increase of lower branched glycoforms.
CONCLUSIONS: Spontaneous mutation in SLC35A3 has been discovered in cattle worldwide, recapitulating the human phenotype with arthrogryposis and additional skeletal defects known as Complex Vertebral Malformation syndrome. The skeletal anomalies in the mutant cattle and in our patients, and perhaps even the neurological symptoms are likely the consequence of the lack of high-branched N-glycans and the concomitant abundance of lower-branched glycoforms at the cell surface. This pattern has previously been associated with growth arrest and induction of differentiation. With this study, we add SLC35A3 to the gene list of autism spectrum disorders, and underscore the crucial importance of UDP-GlcNAc in the regulation of the N-glycan branching pathway in the Golgi apparatus.

Entities:  

Keywords:  Neurology

Mesh:

Substances:

Year:  2013        PMID: 24031089     DOI: 10.1136/jmedgenet-2013-101753

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

Review 1.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

Review 2.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

3.  Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3.

Authors:  M Agustina Toscanini; M Belén Favarolo; F Luis Gonzalez Flecha; Berit Ebert; Carsten Rautengarten; Luis M Bredeston
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

Review 4.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

Review 5.  Pharmacogenetics in Jewish populations.

Authors:  Yao Yang; Inga Peter; Stuart A Scott
Journal:  Drug Metabol Drug Interact       Date:  2014

6.  Biosynthesis of GlcNAc-rich N- and O-glycans in the Golgi apparatus does not require the nucleotide sugar transporter SLC35A3.

Authors:  Bozena Szulc; Paulina Sosicka; Dorota Maszczak-Seneczko; Edyta Skurska; Auhen Shauchuk; Teresa Olczak; Hudson H Freeze; Mariusz Olczak
Journal:  J Biol Chem       Date:  2020-09-16       Impact factor: 5.157

7.  Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1.

Authors:  Bobby G Ng; Carla G Asteggiano; Martin Kircher; Kati J Buckingham; Kimiyo Raymond; Deborah A Nickerson; Jay Shendure; Michael J Bamshad; Matthias Ensslen; Hudson H Freeze
Journal:  Am J Med Genet A       Date:  2017-08-29       Impact factor: 2.802

8.  ALG12-CDG: novel glycophenotype insights endorse the molecular defect.

Authors:  Luisa Sturiale; Sebastiano Bianca; Domenico Garozzo; Alessandra Terracciano; Emanuele Agolini; Angela Messina; Angelo Palmigiano; Francesca Esposito; Chiara Barone; Antonio Novelli; Agata Fiumara; Jaak Jaeken; Rita Barone
Journal:  Glycoconj J       Date:  2019-09-16       Impact factor: 2.916

Review 9.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

Review 10.  Structure and function of nucleotide sugar transporters: Current progress.

Authors:  Barbara Hadley; Andrea Maggioni; Angel Ashikov; Christopher J Day; Thomas Haselhorst; Joe Tiralongo
Journal:  Comput Struct Biotechnol J       Date:  2014-06-11       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.